CEO and President Joe Payne outlined the company’s current focus on messenger RNA (mRNA) therapeutics, emphasizing a leaner ...

A new Covid strain behind a surge of infections in India has sparked fears it could also lead to a rise in cases in the UK. Research indicates Arcturus could be one 1.2 times more infectious than the ...

Dr Tedros Adhanom Ghebreyesus said 'the virus is still changing and is still capable of causing new waves of diseases and death'. (AFP via Getty Images) The leader of the World Health Organization ...

Arcturus Therapeutics Holdings (ARCT) is set to present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, ...

The Arcturus COVID-19 variant has arrived in the United States and is here to stay, according to experts. While it's unclear whether it will drive a summer surge, some doctors are warning that the ...

Earnings Call Insights: Arcturus Therapeutics Holdings Inc. (ARCT) Q2 2025 CEO Joseph E. Payne reported that the ARCT-032 program for Cystic Fibrosis (CF) has completed enrollment and dosing for the 5 ...

Arcturus Therapeutics ARCT announced this morning that it has initiated dosing of its Covid-19 vaccine candidate—LUNAR COV-19, (ARCT-021)—in a Phase 1/2 study in collaboration with Duke-NUS Medical ...

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease ...